Nadia L. Mitchell

Lincoln, CAN 7647, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease.

Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease.

Translational lipidomics reveals BMP and its precursor LPG as biomarkers for CLN5 Batten disease.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

Intrathalamic delivery of adeno-associated viral vector expressing progranulin as gene therapy for GRN-related frontotemporal dementia.

Intrathalamic delivery of adeno-associated viral vector expressing progranulin as gene therapy for GRN-related frontotemporal dementia.

Journal: Molecular therapy. Methods & clinical development

Published: March 03, 2025

Magnetic Resonance Imaging as a Readout of CLN5 Gene Therapy Efficacy in Sheep.

Magnetic Resonance Imaging as a Readout of CLN5 Gene Therapy Efficacy in Sheep.

Journal: Brain and behavior

Published: December 18, 2024

Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten disease.

Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten disease.

Journal: Frontiers in genetics

Published: June 07, 2023

Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease.

Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease.

Journal: Frontiers in pharmacology

Published: May 30, 2023

Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC.

Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC.

Journal: Journal of translational medicine

Published: February 24, 2023

Retinopathy in Greyhound dogs: Prevalence, fundoscopic, and histopathological findings.

Retinopathy in Greyhound dogs: Prevalence, fundoscopic, and histopathological findings.

Journal: Veterinary ophthalmology

Published: February 05, 2023

Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease).

Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease).

Journal: Developmental neurobiology

Published: November 03, 2022

Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment.

Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment.

Journal: Cells

Published: July 25, 2022

Intravitreal Injections in the Ovine Eye.

Intravitreal Injections in the Ovine Eye.

Journal: Journal of visualized experiments : JoVE

Published: July 25, 2022

Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis.

Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis.

Journal: Brain communications

Published: June 16, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026